Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata and atopic dermatitis have similar healthcare costs, but alopecia areata leads to more outpatient and long-term disability expenses.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Denosumab treatment for osteoporosis can cause hair loss.

Phototherapy can help treat hair loss in alopecia areata.

Alopecia areata affects 1 in 50 people, with non-White ethnic groups experiencing the most impact on mental health and work.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Alopecia Areata causes significant structural and compositional changes in hair.

A 5-year-old boy's seasonal hair loss is linked to his allergies.

COVID-19 can increase the risk of hair loss, especially in people over 40.

miR-200c-3p could help diagnose and treat alopecia areata.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Alopecia areata is linked to PTSD, alcohol use, anxiety, and depression.

Younger patients with severe alopecia areata often have nail problems.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Severe alopecia areata may increase the risk of heart-related diseases.

A dog with complete hair loss regrew most hair after treatment, with no relapse after stopping treatment.

Combining oral prednisolone and topical minoxidil effectively reduces hair loss and promotes regrowth in alopecia areata.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Minoxidil injections can speed up hair regrowth in non-severe patchy hair loss, but combining it with steroids doesn't improve results.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

A child used a hair growth lotion for hair loss, but it caused excessive hair growth on his face and neck instead.

Some patients with Alopecia Areata experience itch due to immune cells and enzymes that cause itching.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to their safety and ease of use.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

ILC1 cells contribute to hair loss in alopecia areata.